Jennell Bilek, PharmD, PhD, JD

Adjunct Assistant Professor, Department of Pharmaceutical Care & Health Systems

Jennell Bilek

Contact Info

Office Phone 651-201-2825

Office Address:
2829 University Ave SE, Suite 530, Minneapolis, MN 55414

Mailing Address:
2829 University Ave SE, Suite 530, Minneapolis, MN 55414

PharmD, University of Minnesota

PhD, Social & Administrative Pharmacy, University of Minnesota

BS, Journalism, Iowa State

Juris Doctorate (JD), Mitchell Hamline School of Law


Jennell co-directs the pharmacy law course for the College of Pharmacy. She is the deputy director for the Minnesota Board of Pharmacy. Previously, she was an equity partner at the Twin Cities based law firm, Carlson Caspers. She has served as trial counsel in the U.S. District Court for the District of Delaware and Southern District of New York, and as counsel for many civil lawsuits involving intellectual property disputes that have settled prior to trial. She has also advised clients on a wide range of regulatory and compliance matters relating to prescription and OTC drug products and dietary supplements. Prior to becoming an attorney, Jennell worked as a retail pharmacist and co-founded/managed a pharmacy benefit consulting company that counseled large employers during implementation of their first prescription drug formularies and pharmacy benefit management strategies. She also assisted a pharmaceutical market expert with lawsuits relating to pharmaceutical pricing and promotion, the Hatch Waxman Act, and misappropriations of trade secrets.


Research Summary/Interests

  • Intellectual property (patent, trade secret, and trademark)
  • Regulation of prescription, OTC, and compounded drug products 
  • Health care fraud and compliance
  • Publications

    Bilek JC, The Relationship Between Overall Utilization and Settlements Involving Off-Label Promotion of Prescription Drugs, Ph.D. Dissertation (2013). 

    Bilek JC, Antitrust and the Pharmacist-Patient Relationship, 45 JAPHA 290 (2005). 

    Bilek JC, Sepulveda D, Schondelmeyer SW. Comparative Analyses of Drug Treatment Costs between Therapeutically Similar Alternatives. American Pharmacist Association (APhA) Annual Meeting Supplemental Symposium Proceedings (2005). 

    Bilek JC, Carlson AM, Morris LS. Prescribing Trends for Combination Products in the Treatment of Type II Diabetes. International Society for Pharmacoeconomics and Outcomes Research Annual Meeting Supplemental Symposium Proceedings (2005). 

    Schwartzman DS, Bilek JC, Harvey M, Hoyt RH, Kohler J, Ujhelyi MR. Does Ambulatory 600 mg Oral Propafenone Benefit Patients Managed with Implantable Atrial Defibrillation Therapy? 26(4p2) PACING AND CLINICAL ELECTROCARDIOLOGY 929 (2003).



    PHAR 6778